“Preclinical Potency, Affinity, and Pharmacokinetics of APG990, a Half-Life Extended Antibody Against OX40L”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s551, https://doi.org/10.25251/skin.10.supp.551.